UNICANCER
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.unicancer.fr
Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2012-02-03
- Last Posted Date
- 2022-01-04
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 493
- Registration Number
- NCT01526135
- Locations
- 🇫🇷
CH Layné, Mont de Marsan, France
🇨🇦Dr Leon Richard Oncology Centre, Moncton, New Brunswick, Canada
🇫🇷CHU De ST Eloi, Montpellier, France
MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2011-09-29
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 162
- Registration Number
- NCT01443065
- Locations
- 🇫🇷
Institut Gustave Roussy, Villejuif, France
Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases
- Conditions
- Interventions
- First Posted Date
- 2011-09-29
- Last Posted Date
- 2021-06-18
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 256
- Registration Number
- NCT01442935
- Locations
- 🇫🇷
Centre Val d'Aurelle, Montpellier, France
Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed Uterine
- First Posted Date
- 2011-09-28
- Last Posted Date
- 2020-01-31
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 106
- Registration Number
- NCT01442662
- Locations
- 🇫🇷
Institut Paoli Calmettes, Marseille, France
🇫🇷Centre François Baclesse, Caen, France
🇫🇷Institut Curie - Hopital René Huguenin, Saint Cloud, France
Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.
- First Posted Date
- 2011-09-28
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 700
- Registration Number
- NCT01442246
- Locations
- 🇫🇷
Chu Bordeaux- Hopital Pellegrin, Bordeaux, France
🇫🇷Clinique Victor Pauchet, Amiens, France
🇫🇷Chu Besancon, Besancon, France
Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
- Conditions
- Interventions
- First Posted Date
- 2011-09-28
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 133
- Registration Number
- NCT01442649
- Locations
- 🇫🇷
Centre rené Gauducheau, Saint-herblain, France
Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients
- First Posted Date
- 2011-08-12
- Last Posted Date
- 2022-02-02
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 61
- Registration Number
- NCT01415674
- Locations
- 🇫🇷
CHU d'Angers, Angers, France
🇫🇷Centre François Baclesse, Caen, France
🇫🇷Institut de cancérologie de l'Ouest - Site Paul Papin, Angers, France
High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents
- Conditions
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2017-05-04
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 423
- Registration Number
- NCT01414933
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
🇫🇷Centre François Baclesse, Caen, France
🇫🇷Centre Georges François Leclerc, Dijon, France
Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment
- Conditions
- Interventions
- First Posted Date
- 2011-06-20
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 415
- Registration Number
- NCT01376752
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
🇫🇷Polyclinique Kéraudren, Brest, France
🇫🇷Institut Bergonie, Bordeaux, France
Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer
- Conditions
- Interventions
- First Posted Date
- 2011-06-01
- Last Posted Date
- 2011-06-01
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 61
- Registration Number
- NCT01363466
- Locations
- 🇫🇷
Clinique Sainte Thérèse de l'enfant Jésus, Amiens, France
🇫🇷Clinique Axium, Aix-en-Provence, France
🇫🇷Centre Hospitalier Universitaire, Amiens, France